Establishing secure connection…Loading editor…Preparing document…

Healthcare Research Study Consent Form

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

Healthcare Research Study Consent Form

Study Identification

Study Title:

Participant Information

Date of Birth:     Gender:

Phone:     Email:

Emergency Contact

Relationship:     Phone:

Insurance Information (If applicable)

Policy Number:     Group Number:

Medical History

Study Procedure, Risks and Benefits

Purpose: The purpose of this research study is to collect clinical and/or behavioral data to evaluate the safety and effectiveness of the described intervention. The principal investigator will explain the specific aims verbally and in writing.

Procedures: Participation involves the following procedures: clinical assessments, collection of biological samples, study-specific imaging or monitoring, questionnaires, and follow-up visits as described in the study protocol. The estimated total time commitment is described in the study materials provided to you.

Risks: Participation may involve risks including, but not limited to, physical discomfort, allergic reaction, breach of confidentiality, psychological distress, and other risks described in the study information sheet. Unforeseen risks may occur.

Potential Benefits: You may receive no direct medical benefit from participation. Information gained may contribute to scientific knowledge and may benefit future patients.

Alternatives, Compensation, and Costs

Alternatives: Participation is voluntary. You may choose not to participate or to withdraw at any time. Your decision will not affect your access to standard medical care or your relationship with the treating clinicians.

Confidentiality and HIPAA Authorization

Confidentiality: Reasonable efforts will be made to keep your records confidential. Study data will be stored in secure systems and access limited to authorized study personnel. Identifiable information may be removed and replaced with a code for data analysis.

HIPAA Authorization: I authorize the use and disclosure of my protected health information (PHI) as necessary for this research study and related monitoring, auditing, regulatory compliance, and publication in de-identified form.

I authorize the use and disclosure of PHI for the purposes described above.

Expiration: This authorization will expire on:    or upon completion of the study procedures, whichever occurs first.

Participant Affirmations

By checking the following boxes and signing below, I affirm that I have read and understand the information provided, had the opportunity to ask questions, and that these questions were answered to my satisfaction.

I understand the purpose and procedures of the study.

I understand the risks and possible discomforts.

I understand that participation is voluntary and I may withdraw at any time without penalty.

Questions and Contacts

If you have questions about the study, contact the principal investigator:

Phone:     Email:

Consent and Authorization

I have read (or someone has read to me) the information in this form. I have been given the opportunity to ask questions and all questions have been answered to my satisfaction. I voluntarily agree to participate in this research study and authorize the use of my health information as described above.

Printed Name:

Relationship (if not participant):

Signature:

Date:

Enter text✕

What the Healthcare Research Study Consent Form is and why it matters

The Healthcare Research Study Consent Form documents a prospective participant’s voluntary agreement to join a clinical, translational, or observational research project. It describes study purpose, procedures, anticipated risks and benefits, data collection and retention, confidentiality safeguards, alternatives to participation, and compensation or reimbursement. For U.S. studies the form commonly includes HIPAA-authorized disclosures for use and disclosure of protected health information and fields for signature and date. Properly completed consent forms provide the official record required for IRB review and regulatory inspection.

Why a clear consent form protects participants and your study

A well-drafted Healthcare Research Study Consent Form documents informed consent, clarifies data use and participant rights, and supports IRB and sponsor oversight while reducing legal and compliance risk.

Why a clear consent form protects participants and your study

Who typically completes and manages the consent form

Research coordinators, principal investigators, IRB administrators, and study sponsors use and maintain consent forms during participant enrollment.

  • Participants and legally authorized representatives who provide informed consent and sign the form prior to study procedures.
  • Clinical site staff responsible for obtaining consent, answering participant questions, and documenting the process for audit.
  • Institutional Review Boards and sponsor monitors who approve, archive, and inspect consent documentation for compliance.

Representatives from clinical sites, data management teams, and legal/compliance groups also review forms to ensure regulatory and privacy alignment.

Step-by-step: obtaining valid informed consent

Follow these steps to document informed consent consistently and maintain a defensible audit trail for the study.

  • 01
    Prepare form: Confirm IRB-approved version and study identifiers.
  • 02
    Review with participant: Explain procedures, risks, benefits, and alternatives in plain language.
  • 03
    Record consent: Capture signature, date, and any representative details.
  • 04
    Store signed copy: Archive per study SOPs and retention rules.

Where completed consent forms typically go

Completed Healthcare Research Study Consent Forms are routed based on IRB, sponsor, and institutional policies; routing should be documented in the study SOP.

  • Institutional Records: Site retains original signed copy in secure study files.
  • IRB Office: Submit signed form as required for monitoring and audits.
  • Sponsor: Provide redacted or full copies per trial agreement.
  • Participant: Give participant a signed copy for their records.

Digital workflow settings to capture valid consent

Configure electronic workflows so signature authentication, PHI handling, and audit trails meet study and institutional requirements.

Field Configuration
Authentication Email link, SMS code, or stronger MFA
Signature Type Typed, drawn, or PKI-based digital signature
Audit Trail Capture IP, timestamp, and signer steps
PHI Handling Restrict access, encrypt in transit and at rest

Platform and file requirements for electronic consent

Choose a platform that supports secure storage, audit trails, and required integrations for clinical workflows.

  • Integrations: Salesforce, Microsoft 365, NetSuite, Google Workspace, Box, Procore and other EMR or document systems
  • File formats: PDF and Word DOCX for archival and audit use
  • Authentication: Email link, SMS code, KBA, SSO/SAML

Security and compliance elements to include

Encryption: TLS 1.2/1.3 in transit; AES-256 at rest
HIPAA: BAA required for protected health information
Audit Trail: Immutable timestamps and signer metadata
Certifications: SOC 2 Type II and ISO 27001 available
21 CFR Part 11: Controls for FDA-regulated records supported
Accessibility: WCAG 2.0 Level AA compliance options

Consequences of incomplete or improper consent

Invalid consent: Could jeopardize study data admissibility
HIPAA breach fines: Civil and administrative penalties possible
IRB sanctions: Suspension or termination of study approval
Regulatory action: FDA or sponsor enforcement in trials
Civil liability: Participant injury claims or litigation
Data loss: Loss of research integrity and funding

Common mistakes to avoid when preparing consent forms

  • Using an outdated IRB-approved template rather than the current approved version leads to noncompliance and potential audit findings.
  • Failing to include required HIPAA authorization language or specifying data recipients can block lawful data sharing and analysis.
  • Collecting electronic signatures without a reliable audit trail or proper authentication weakens proof of informed consent and signer attribution.
  • Not providing a signed copy to the participant or failing to document verbal consent exceptions causes operational and legal issues.

Timing and reporting expectations for consent forms

Consent paperwork must align with IRB approvals and study start dates; adverse events and withdrawals have their own reporting windows.

IRB approval before enrollment:

Do not enroll participants before IRB-approved consent is in place

Adverse event reporting:

Report per protocol and IRB timelines immediately

Withdrawal recording:

Document participant revocation date and scope

Periodic review:

Update consent documents when protocol changes occur

Retention trigger:

Retention periods begin on consent date or study end

Vendor pricing and capability snapshot for consent eSignature solutions

This table summarizes starting prices and core features across common eSignature vendors; signNow appears first for direct comparison.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial Varies by vendor Varies by vendor Varies by vendor Varies by vendor
Bulk Send Yes (Premium tier) Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Real-world examples of consent form workflows

Two concise use cases show how consent forms are handled in different research settings and the impact on operations.

Academic Medical Center

A tertiary care research team implemented electronic consent for minimal-risk studies to reduce scheduling delays.

  • The system captured audit trails and PHI consents.
  • As a result, enrollment throughput increased while maintaining IRB-required documentation and secure storage for participant records, enabling faster monitoring and sponsor reporting.

Multi-site Clinical Trial

A contract research organization standardized consent templates across sites to ensure consistent disclosures.

  • Coordinated digital signatures and central storage.
  • This improved version control, reduced local administrative burden, and provided sponsors with a queryable repository for monitoring and regulatory inspection.

Frequently asked questions about consent forms and e-signatures

Answers to common questions about electronic consent, withdrawal, authentication, and retention for U.S.-based research.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users